AAAAAA

   
Results: 1-7 |
Results: 7

Authors: GARCIADELMURO X VADELL C MANGA GP BOVER I RIFA J BELTRAN M BARROS MM GERMA JR FABREGAT X MORENO V SALVADOR A VILADIU P
Citation: X. Garciadelmuro et al., RANDOMIZED DOUBLE-BLIND-STUDY COMPARING TROPISETRON ALONE AND IN COMBINATION WITH DEXAMETHASONE IN THE PREVENTION OF ACUTE AND DELAYED CISPLATIN-INDUCED EMESIS, European journal of cancer, 34(1), 1998, pp. 193-195

Authors: VADELL C SEGUI MA GIMENEZARNAU JM MORALES S CIRERA L BESTIT I BATISTE E BLANCO R JOLIS L BOLEDA M ANTON I
Citation: C. Vadell et al., ANTICACHECTIC EFFICACY OF MEGESTROL-ACETATE AT DIFFERENT DOSES AND VERSUS PLACEBO IN PATIENTS WITH NEOPLASTIC CACHEXIA, American journal of clinical oncology, 21(4), 1998, pp. 347-351

Authors: GRAUS F DALMAU J RENE R TORA M MALATS N VERSCHUUREN JJ CARDENAL F VINOLAS N DELMURO JG VADELL C MASON WP ROSELL R POSNER JB REAL FX
Citation: F. Graus et al., ANTI-HU ANTIBODIES IN PATIENTS WITH SMALL-CELL LUNG-CANCER - ASSOCIATION WITH COMPLETE RESPONSE TO THERAPY AND IMPROVED SURVIVAL, Journal of clinical oncology, 15(8), 1997, pp. 2866-2872

Authors: MOYSSET I LLORETA J MIGUEL A VADELL C RIBALTA T ESTRACH T SERRANO S
Citation: I. Moysset et al., THYMOMA ASSOCIATED WITH CD4-INFECTION, AND KAPOSIS-SARCOMA( LYMPHOPENIA, CYTOMEGALOVIRUS), Human pathology, 28(10), 1997, pp. 1211-1213

Authors: ROSELL R LI SR ANTON A MORENO I MARTINEZ E VADELL C MATE JL ARIZA A MONZO M FONT A MOLINA F DEANTA JM PIFARRE A
Citation: R. Rosell et al., PROGNOSTIC VALUE OF K-RAS 12 GENOTYPES IN PATIENTS WITH ADVANCED NONSMALL CELL LUNG-CANCER RECEIVING CARBOPLATIN WITH EITHER INTRAVENOUS ORCHRONIC ORAL DOSE ETOPOSIDE, International journal of oncology, 5(2), 1994, pp. 169-176

Authors: LLORETA J VADELL C FABREGAT X SERRANO S
Citation: J. Lloreta et al., FIBROLAMELLAR HEPATIC TUMOR WITH NEUROSECRETORY FEATURES AND SYSTEMICDEPOSITION OF AA AMYLOID, Ultrastructural pathology, 18(1-2), 1994, pp. 287-292

Authors: ROSELL R GOMEZCODINA J ANTON A SANCHEZ JJ VADELL C
Citation: R. Rosell et al., ESCALATING HIGH-DOSE EPIRUBICIN PLUS CISPLATIN IN SMALL-CELL LUNG-CANCER WITH GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR USE WHEN APPROPRIATE, Seminars in oncology, 21(1), 1994, pp. 48-53
Risultati: 1-7 |